8. Huntington disease Clinical trials / Disease details


Clinical trials : 229 Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02509793
(ClinicalTrials.gov)
August 1, 201824/7/2015A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)Huntington's DiseaseDrug: TetrabenazineWilliam Ondo, MDH. Lundbeck A/SRecruiting18 Years80 YearsAll20Phase 4United States
2NCT00632645
(ClinicalTrials.gov)
April 200929/2/2008Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and TiaprideNeuroleptic and Huntington Disease. Comparison of : Olanzapine, la Tetrabenazine and Tiapride. A Multicentric, Randomised, Controlled Study.Huntington DiseaseDrug: Olanzapine;Drug: Xenazine;Drug: TiapridalAssistance Publique - Hôpitaux de ParisNULLCompleted18 YearsN/AAll180Phase 3France